SBI Healthcare Opportunities Fund - Regular Plan -Growth
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 14-07-1999
AUM:
₹ 3,933.26 Cr
Expense Ratio
1.94%
Benchmark
BSE Healthcare TRI
ISIN
INF200K01446
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
500
Fund Manager
Mr. Tanmaya Desai,
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| SBI Healthcare Opportunities Fund - Regular Plan -Growth | 7.07 | 25.68 | 19.81 |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
437.8891
Last change
-2.57 (-0.5866%)
Fund Size (AUM)
₹ 3,933.26 Cr
Performance
15.45% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
To provide the investors with the opportunity of long term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Fund Manager
Mr. Tanmaya Desai,
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 10.94 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 6.36 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 5.67 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 4.59 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 4.08 |
| Lonza Group | 4.06 |
| TREPS | 3.85 |
| FORTIS HEALTHCARE LIMITED. EQ | 3.7 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 3.66 |
| GLAND PHARMA LIMITED EQ NEW FV Re.1/- | 3.54 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 88.75 |
| Chemicals | 2.68 |
| Consumer Services | 0.87 |